Nanosonics Limited (ASX: NAN)

Market Cap	1.08B
Revenue (ttm)	170.01M
Net Income (ttm)	12.97M
Shares Out	305.80M
EPS (ttm)	0.04
PE Ratio	84.05
Forward PE	84.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	163,803
Average Volume	312,454
Open	3.530
Previous Close	3.530
Day's Range	3.500 - 3.600
52-Week Range	2.590 - 4.450
Beta	1.58
RSI	81.21
Earnings Date	Feb 19, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.